J&J’s New Path Forward – An Interview With Alex Gorsky
Executive Summary
In a conversation shortly before taking the helm at Johnson & Johnson, CEO Gorsky discusses deal strategies, emerging markets, his experience on both the device and pharma sides of the business, and opportunities for drug/device convergence.